<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0">
<title>AAAM Board Review Exam - Practice Quiz</title>
<script src="https://cdn.tailwindcss.com"></script>
<style>
@import url('https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700&display=swap');
body { font-family: 'Inter', sans-serif; background-color: #f7f7f9; }
.card { background-color: white; box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -2px rgba(0, 0, 0, 0.05); }
.correct { background-color: #d1fae5; border-color: #10b981; }
.incorrect { background-color: #fee2e2; border-color: #ef4444; }
</style>
</head>
<body>
<div id="app" class="min-h-screen p-4 sm:p-8">
<header class="text-center mb-8">
<h1 class="text-4xl font-extrabold text-blue-800">AAAM Level 2 Board Review</h1>
<p class="text-lg text-gray-600 mt-2">Interactive Quiz: Practice Mode (800 Questions)</p>
</header>
<!-- Topic Selection and Start Screen -->
<div id="start-screen" class="max-w-3xl mx-auto card p-6 sm:p-10 rounded-xl">
<h2 class="text-2xl font-bold mb-4 text-gray-800">Select a Topic to Begin:</h2>
<div id="topic-list" class="grid grid-cols-1 md:grid-cols-2 gap-4">
<!-- Topics will be dynamically inserted here -->
</div>
<div class="mt-8 p-4 bg-yellow-100 border border-yellow-300 rounded-lg text-sm">
<p><strong>Note:</strong> Each question appears twice for reinforced learning (400 unique questions total). Select 'All Topics' for a randomized full exam simulation. No data is saved, making it fully portable for offline use!</p>
</div>
</div>
<!-- Quiz Area -->
<div id="quiz-area" class="max-w-4xl mx-auto hidden">
<div class="mb-6 p-4 rounded-xl bg-blue-50 text-blue-800 flex justify-between items-center text-sm sm:text-base">
<span id="quiz-topic" class="font-semibold text-lg"></span>
<span id="progress-indicator" class="font-medium">Question 1/800</span>
</div>
<!-- Question Card -->
<div class="card p-6 sm:p-8 rounded-xl">
<p id="question-text" class="text-xl font-semibold mb-6 text-gray-900"></p>
<div id="options-container" class="space-y-4">
<!-- Options buttons will be inserted here -->
</div>
</div>
<!-- Feedback & Next Button -->
<div id="feedback-area" class="mt-6 p-5 border-l-4 hidden rounded-xl card transition-all duration-300">
<p class="font-bold text-lg mb-2">Feedback:</p>
<p id="explanation-text" class="text-gray-700"></p>
<div class="mt-4 flex justify-end">
<button onclick="nextQuestion()" class="bg-blue-600 hover:bg-blue-700 text-white font-bold py-3 px-6 rounded-lg transition duration-150 shadow-md">
Next Question
</button>
</div>
</div>
</div>
<!-- Results Screen -->
<div id="results-screen" class="max-w-2xl mx-auto card p-10 rounded-xl hidden text-center">
<h2 class="text-3xl font-bold text-green-700 mb-4">Quiz Complete!</h2>
<p class="text-xl text-gray-700 mb-6">You have finished the practice session for this topic.</p>
<p class="text-4xl font-extrabold text-blue-800 mb-2" id="score-display">0/0</p>
<p class="text-lg font-medium text-gray-600">Total Correct Answers</p>
<button onclick="resetQuiz()" class="mt-8 bg-blue-600 hover:bg-blue-700 text-white font-bold py-3 px-8 rounded-lg shadow-lg">
Start New Quiz
</button>
</div>
</div>
<script>
// --- QUESTION DATA STRUCTURE ---
const ALL_QUESTIONS = [
// 1. Platelet Rich Plasma (PRP) - 40 Unique Questions (80 Total)
{topic: "Platelet Rich Plasma (PRP)", q: "What is the minimum platelet concentration level in PRP, relative to baseline, accepted by the American Red Cross?", options: ["1.5 times baseline", "2 times baseline", "3 times baseline", "5 times baseline"], a: "2 times baseline", exp: "The American Red Cross defines Platelet Rich Plasma (PRP) as having >2x platelets above baseline levels. Most commercial systems aim for 2-5 times baseline. "},
{topic: "Platelet Rich Plasma (PRP)", q: "Why are systemic corticosteroids and NSAIDs typically avoided immediately following a PRP injection?", options: ["They inhibit the necessary inflammatory process for PRP to work.", "They prolong the breakdown of growth factors.", "They increase the risk of bruising.", "They can cause systemic toxicity."], a: "They inhibit the necessary inflammatory process for PRP to work.", exp: "NSAIDs and corticosteroids suppress the acute inflammation, which is a necessary initial phase of the wound healing cascade triggered by PRP to promote regeneration."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which key factor is highly abundant in activated platelets and strongly stimulates fibroblast proliferation and is key for collagen production?", options: ["Vascular Endothelial Growth Factor (VEGF)", "Platelet Derived Growth Factor (PDGF)", "Transforming Growth Factor Beta (TGF-β)", "Epidermal Growth Factor (EGF)"], a: "Platelet Derived Growth Factor (PDGF)", exp: "PDGF is one of the most abundant growth factors released, vital for cell growth, new blood vessel repair, and collagen production."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which systemic condition is a contraindication for PRP therapy due to its role in producing platelet-fibrin, the basic mesh for tissue healing?", options: ["Chronic Kidney Disease", "Severe Liver Disease", "Hypothyroidism", "Controlled Hypertension"], a: "Severe Liver Disease", exp: "Severe Liver Disease can lead to insufficient fibrin production, which is essential for the platelet-fibrin mesh to form effectively at the site of injection."},
{topic: "Platelet Rich Plasma (PRP)", q: "The anti-apoptotic effect of Platelet Rich Plasma on dermal papilla cells is primarily mediated by the activation of which substance?", options: ["Vascular Endothelial Growth Factor (VEGF)", "Protein Kinase B (Akt)", "Bcl-2-associated death promoter (BAD)", "Fibroblast Growth Factor (FGF)"], a: "Protein Kinase B (Akt)", exp: "Growth factors activate Protein Kinase B (Akt), which blocks the degradation of $\\beta$-catenin and the Bcl-2-associated death promoter (BAD), resulting in cell proliferation and survival."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which platelet granule type is responsible for releasing small molecules like ADP, ATP, Serotonin, and Epinephrine?", options: ["Lysosomes", "Alpha-granules", "Dense granules", "Gamma-granules"], a: "Dense granules", exp: "Dense granules contain small, non-protein molecules such as ADP, ATP, Serotonin, Calcium, and Epinephrine, which promote coagulation and influence cell signaling."},
{topic: "Platelet Rich Plasma (PRP)", q: "PRP injected in the deep dermis/subdermis induces formation of new collagen, blood vessels, and adipose tissue, a process collectively known as:", options: ["Necrotic apoptosis", "Ablative photothermolysis", "Angiogenesis and adipogenesis", "Epidermal melanogenesis"], a: "Angiogenesis and adipogenesis", exp: "PRP induces soft-tissue augmentation, new collagen deposition, new blood vessels (angiogenesis) and adipose tissue (adipogenesis) formation."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which indication showed the most significant improvement with a single PRP intradermal injection in studies on facial wrinkles?", options: ["Crow's feet wrinkles", "Transverse forehead lines", "Glabellar lines", "Nasolabial folds (NLFs)"], a: "Nasolabial folds (NLFs)", exp: "Clinical studies indicated that Nasolabial Folds (NLFs) were the most responsive wrinkle type, particularly in younger subjects with mild-to-moderate wrinkles."},
{topic: "Platelet Rich Plasma (PRP)", q: "According to post-procedure guidelines, which common post-injection relief measure should be AVOIDED for the first 72 hours after PRP injection?", options: ["Tylenol (Acetaminophen)", "Applying ice to the injection site", "Gentle range of motion", "Avoiding alcohol consumption"], a: "Applying ice to the injection site", exp: "Ice should be avoided for the first 72 hours as it prevents the initial inflammatory cascade necessary to initiate the regenerative process."},
{topic: "Platelet Rich Plasma (PRP)", q: "The combined use of PRP with a fractional Erbium-YAG Laser for atrophic acne scars showed what result compared to either treatment alone?", options: ["Worse results than either treatment alone.", "Only equal results to laser alone.", "Superior results compared to either treatment alone.", "Only effective for rolling scars."], a: "Superior results compared to either treatment alone.", exp: "The combined approach leverages the laser's ablation with PRP's growth factors for enhanced neocollagenesis and remodeling."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which component is NOT a major contributor to the effect of PRP, as it is generally reduced or discarded during preparation?", options: ["Platelets", "Growth Factors", "Platelet Poor Plasma (PPP)", "Clotting Factors"], a: "Platelet Poor Plasma (PPP)", exp: "PRP is concentrated to minimize the volume of PPP. The final product should be enriched plasma with platelets, growth factors, and clotting factors."},
{topic: "Platelet Rich Plasma (PRP)", q: "What does the term 'autologous' mean in relation to Platelet Rich Plasma therapy?", options: ["Derived from an animal source.", "Processed using two steps of centrifugation.", "Obtained from the patient's own blood.", "Activated using Calcium Chloride."], a: "Obtained from the patient's own blood.", exp: "Autologous products originate from the patient's own body, minimizing the risk of immunogenic reactions and disease transmission."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which key action is catalyzed by Vascular Endothelial Growth Factor (VEGF) in wound healing and regeneration?", options: ["Inhibition of stem cell migration.", "Mitogenesis of dermal fibroblasts.", "Angiogenesis (new blood vessel formation).", "Blocking cell survival."], a: "Angiogenesis (new blood vessel formation).", exp: "VEGF is a potent stimulator of vascular endothelial cells, promoting the growth and generation of new blood vessels."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which finding supports the use of PRP for facial skin rejuvenation, as documented by instrumental studies (Cutometer, Visioscan)?", options: ["Immediate skin tightening (tissue contraction).", "A significant increase in skin gross elasticity and smoothness.", "Permanent elimination of all fine lines.", "Reduced density of collagen fibers."], a: "A significant increase in skin gross elasticity and smoothness.", exp: "Studies showed PRP significantly improved skin gross elasticity, barrier function, and smoothness (Visioscan texture parameters)."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which is a characteristic of Platelets (Thrombocytes)?", options: ["They are nucleated, large cellular elements.", "They develop from the lymph nodes.", "Their density is approximately $2 \\mu m$ in diameter.", "They primarily function in oxygen transport."], a: "Their density is approximately $2 \\mu m$ in diameter.", exp: "Platelets are non-nucleated, discoid cellular elements, approximately $2 \\mu m$ in diameter, and function in hemostasis and coagulation."},
{topic: "Platelet Rich Plasma (PRP)", q: "What should be checked when collecting blood for PRP preparation to avoid a therapeutic failure?", options: ["The patient's iron levels.", "The expiration date of the anticoagulant tubes.", "The patient's body mass index (BMI).", "The patient's age."], a: "The expiration date of the anticoagulant tubes.", exp: "The tubes used must contain an active anticoagulant (like ACD or citrate) and must not be expired to ensure the platelets remain functional and do not activate prematurely."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which PRP growth factor is strongly linked to the maintenance of hair follicle growth in vitro and increases perifollicular vessel size during the anagen phase?", options: ["Transforming Growth Factor Beta (TGF-$\\beta$)", "Insulin-like Growth Factor (IGF-1)", "Macrophage Inhibitory Protein (MIP-1$\\alpha$)", "Platelet Factor 4 (PF4)"], a: "Insulin-like Growth Factor (IGF-1)", exp: "IGF-1 increases hair growth and maintains hair follicle growth. VEGF is also expressed in the DP cells in the anagen phase and regulates perifollicular angiogenesis."},
{topic: "Platelet Rich Plasma (PRP)", q: "The immediate response to PRP injection that involves Macrophage activation and Mitogenesis is typically initiated by which growth factor?", options: ["Epidermal Growth Factor (EGF)", "Transforming Growth Factor Beta (TGF-$\\beta$)", "Platelet Derived Growth Factor (PDGF)", "Keratinocyte Growth Factor (KGF)"], a: "Platelet Derived Growth Factor (PDGF)", exp: "PDGF is prominently associated with mitogenesis and the recruitment and activation of macrophages and other cells early in the healing process."},
{topic: "Platelet Rich Plasma (PRP)", q: "In the context of tissue regeneration, PRP is noted to aid long-term healing, bone regeneration & modeling, and the regulation of inflammatory processes through which key factor?", options: ["Platelet Derived Growth Factor (PDGF)", "Vascular Endothelial Growth Factor (VEGF)", "Transforming Growth Factor Beta (TGF-$\\beta$)", "Epithelial Growth Factor (EGF)"], a: "Transforming Growth Factor Beta (TGF-$\\beta$)", exp: "TGF-$\\beta$ plays a pivotal role in the later phases of healing, including bone regeneration, modeling, and controlling the immune response."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which statement best describes the current consensus on the definition and preparation of Platelet Rich Plasma?", options: ["There is a single, universally defined protocol and concentration.", "There are multiple systems/preparations, with no current consensus on the optimal definition or concentration.", "All methods must achieve a concentration of exactly $5 \\times$ baseline.", "PRP must only be activated using thrombin."], a: "There are multiple systems/preparations, with no current consensus on the optimal definition or concentration.", exp: "The AAAM material notes that despite various commercial systems, there is currently 'No consensus on definition' or optimal concentration for therapeutic use."},
{topic: "Platelet Rich Plasma (PRP)", q: "What is the consequence of smoking (containing tar) on the body's ability to heal after PRP therapy?", options: ["It increases the body's ability to create stem cells.", "It hampers the production of growth factors.", "It directly activates platelets prematurely.", "It has no effect on the outcomes."], a: "It hampers the production of growth factors.", exp: "Smoking is a contraindication as cigarettes contain tar that can hamper the production of growth factors and negatively affect healing and platelet count."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which step in a two-spin PRP preparation protocol separates the red and white blood cells and concentrates platelets at various levels?", options: ["The first spin (soft spin).", "The second spin (hard spin).", "The activation step.", "The whole blood draw."], a: "The first spin (soft spin).", exp: "The first spin separates the plasma layer containing the buffy coat (WBCs and platelets) from the RBCs. The second spin concentrates the platelets to form a pellet."},
{topic: "Platelet Rich Plasma (PRP)", q: "A possible complication of injecting PRP is nerve trauma. Where is PRP typically injected to minimize this risk?", options: ["Intralesional or perilesional.", "Directly into major nerve trunks.", "Deep into the periosteum.", "Into the intravascular space."], a: "Intralesional or perilesional.", exp: "PRP is injected into or around the target lesion/tissue (intralesional/perilesional) using precise techniques, avoiding direct nerve bundles."},
{topic: "Platelet Rich Plasma (PRP)", q: "What is the minimum practical experience period in Aesthetic Medicine required after completing Levels 1 & 2 before Diplomates are eligible for the AAAM Board Certification exam?", options: ["Three months", "Six months", "One year", "Two years"], a: "Six months", exp: "Eligibility requires successfully completing Levels 1 & 2 AND a minimum of six months of practical experience in Aesthetic Medicine."},
{topic: "Platelet Rich Plasma (PRP)", q: "What percentage passing grade is required on the 100 multiple-choice questions portion of the AAAM Board Certification exam?", options: ["$60\\%$", "$65\\%$", "$70\\%$", "$75\\%$"], a: "$70\\%$", exp: "The written exam requires a $70\\%$ passing grade for admission to the oral exam."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which factor primarily influences the volume and flow rate of PRP through the coagulation cascade after injection?", options: ["The concentration of IGF-1.", "The presence of activating agents (e.g., calcium chloride).", "The temperature of the PRP.", "The patient's hydration level."], a: "The presence of activating agents (e.g., calcium chloride).", exp: "The activating agent (like calcium chloride) initiates the coagulation cascade, causing platelets to release their contents and form the fibrin matrix, influencing the flow and tissue interaction."},
{topic: "Platelet Rich Plasma (PRP)", q: "The term for when PRP is used as the only treatment modality for facial rejuvenation, hair restoration, or scar treatment is:", options: ["Combination Therapy", "Synergistic Treatment", "Monotherapy", "PRP-Matrix"], a: "Monotherapy", exp: "Monotherapy refers to using PRP alone, without combining it with other active treatments like lasers or fillers."},
{topic: "Platelet Rich Plasma (PRP)", q: "What type of cellular element are platelets (thrombocytes)?", options: ["Large, nucleated blood cells.", "Small, discoid, non-nucleated cellular fragments.", "A type of T-lymphocyte.", "The largest components of blood plasma."], a: "Small, discoid, non-nucleated cellular fragments.", exp: "Platelets are small, discoid, non-nucleated fragments with a diameter of approximately $2 \\mu m$. "},
{topic: "Platelet Rich Plasma (PRP)", q: "Why is pregnancy or breastfeeding considered a contraindication for PRP therapy?", options: ["High risk of severe allergic reaction.", "The possibility of infections from PRP therapy is possible, though remote.", "The procedure is too painful.", "It is an FDA-mandated exclusion for all autologous products."], a: "The possibility of infections from PRP therapy is possible, though remote.", exp: "While remote, the possibility of infections from PRP therapy is possible and must be avoided during pregnancy or breastfeeding."},
{topic: "Platelet Rich Plasma (PRP)", q: "A study assessing facial rejuvenation with PRP found that the treatment resulted in a greater satisfaction with overall facial appearance and cheeks, as measured by which patient-reported outcome measure (PROM)?", options: ["Wrinkle Severity Rating Scale (WSRS)", "Global Aesthetic Improvement Scale (GAIS)", "FACE-Q appearance appraisal scales", "Fitzpatrick Scale"], a: "FACE-Q appearance appraisal scales", exp: "The FACE-Q (Face-Q questionnaire) is a patient-reported outcome measure used to evaluate satisfaction and quality of life following facial aesthetic procedures."},
{topic: "Platelet Rich Plasma (PRP)", q: "The concentration ratio of platelets (2-5 times baseline) is generally achieved through which laboratory technique?", options: ["Chromatography", "Polymerase Chain Reaction (PCR)", "Centrifugation", "Electrophoresis"], a: "Centrifugation", exp: "Centrifugation (typically a two-spin protocol) separates the components of the blood to isolate and concentrate the platelet-rich fraction."},
{topic: "Platelet Rich Plasma (PRP)", q: "In the wound healing process, the step immediately following Platelet Activation and Coagulation Cascade is:", options: ["Epithelization", "Remodeling", "Inflammation (Macrophage/Neutrophil activation)", "Fibroblast Proliferation"], a: "Inflammation (Macrophage/Neutrophil activation)", exp: "The full process starts with Injury $\\rightarrow$ Coagulation $\\rightarrow$ **Inflammation** $\\rightarrow$ Fibroblast Proliferation $\\rightarrow$ Tissue Granulation $\\rightarrow$ Epithelization $\\rightarrow$ Remodeling $\\rightarrow$ Healed Tissue. "},
{topic: "Platelet Rich Plasma (PRP)", q: "The use of Platelet Rich Plasma is indicated for orthopaedic applications, including injuries to tendons and knees, and which age-related condition?", options: ["Rheumatoid Arthritis (RA)", "Gout", "Osteoarthritis (OA)", "Osteoporosis"], a: "Osteoarthritis (OA)", exp: "PRP is indicated for various musculoskeletal issues, including sports injuries and the treatment of bone loss and Osteoarthritis (OA)."},
{topic: "Platelet Rich Plasma (PRP)", q: "What advice should be given to a patient about exercise for the first 3-14 days post-PRP injection?", options: ["Aggressive exercise should be performed immediately.", "Avoid all movement for 14 days.", "Gentle range of motion is encouraged, avoiding aggressive exercise for up to 4 weeks.", "High-impact exercise is mandatory for growth factor release."], a: "Gentle range of motion is encouraged, avoiding aggressive exercise for up to 4 weeks.", exp: "Gentle range of motion is encouraged initially, but aggressive exercise or activity should be avoided for up to 4 weeks."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which growth factor mediates the formation of new blood vessels, protecting the heart from injury in animal studies, and has low levels linked to excessive anxiety?", options: ["Platelet Derived Growth Factor (PDGF)", "Fibroblast Growth Factor (FGF)", "Transforming Growth Factor Beta (TGF-$\\beta$)", "Keratinocyte Growth Factor (KGF)"], a: "Fibroblast Growth Factor (FGF)", exp: "FGF is hypothesized to be activated during wound healing to mediate angiogenesis and has been studied for its role in cardiac protection and mood regulation."},
{topic: "Platelet Rich Plasma (PRP)", q: "For hair restoration, PRP's mechanism of action involves proliferation, migration, cell differentiation, and what other main action in the local environment?", options: ["Vasoconstriction", "Anhidrosis", "Angiogenesis", "Apoptosis"], a: "Angiogenesis", exp: "The GFs and bioactive molecules promote cell proliferation, migration, cell differentiation, and angiogenesis."},
{topic: "Platelet Rich Plasma (PRP)", q: "PRP is considered immunologically neutral and poses no danger of reactions, primarily because it is:", options: ["Synthetic and bio-inert.", "Processed using sterile techniques.", "Activated with calcium chloride.", "Autologous (derived from the patient's own body)."], a: "Autologous (derived from the patient's own body).", exp: "As an autologous product, PRP is recognized by the body, meaning it is immunologically neutral and has virtually no risk of allergic reaction (unlike xenogeneic or allogeneic products)."},
{topic: "Platelet Rich Plasma (PRP)", q: "Which indication utilizes Platelet-Rich Fibrin (PRF), which is useful because it results in a longer period of cellular activation than simple PRP?", options: ["Facial Rejuvenation", "Hair Regeneration", "Acne Treatment", "Scar Treatment"], a: "Hair Regeneration", exp: "PRF results in a slower release of growth factors compared to traditional PRP, providing a longer period of cellular activation, which is advantageous for hair regeneration."},
{topic: "Platelet Rich Plasma (PRP)", q: "What anatomical area benefits from PRP injection both intradermally (to thicken skin) and deeper subdermally (to regenerate deeper tissues/muscles)?", options: ["Nasolabial folds", "Hands", "Scalp", "Under the eye (infraorbital area)"], a: "Under the eye (infraorbital area)", exp: "PRP is injected under the eye both superficially to thicken thin skin and deeply to regenerate supporting tissues and tighten the area around the eye."},
{topic: "Platelet Rich Plasma (PRP)", q: "What distinguishes Platelet-Rich Fibrin (PRF) from Platelet Rich Plasma (PRP) in terms of preparation and activation?", options: ["PRF uses more centrifugation spins.", "PRF requires a synthetic activator like Thrombin.", "PRF forms a fibrin matrix naturally without exogenous anticoagulants or thrombin.", "PRF has a lower concentration of growth factors."], a: "PRF forms a fibrin matrix naturally without exogenous anticoagulants or thrombin.", exp: "PRF techniques typically involve slower, lower-speed centrifugation of tubes without anticoagulants, allowing the natural formation of a slow-releasing fibrin clot."},
// 2. Microneedling - 40 Unique Questions (80 Total)
{topic: "Microneedling", q: "The primary mechanism of action for Microneedling is the induction of a controlled wound healing response, which primarily stimulates the increased synthesis of:", options: ["Lipids and ceramides", "Collagen, elastin, and GAGs", "Melanin and tyrosinase", "Immunoglobulin A and E"], a: "Collagen, elastin, and GAGs", exp: "The mechanical trauma induces dermal remodeling, encouraging the skin to produce new collagen, elastin, and Glycosaminoglycans (GAGs)."},
{topic: "Microneedling", q: "How long after a Microneedling procedure should a patient typically expect to see the full, long-lasting results from dermal remodeling?", options: ["Immediately", "1 week", "4-6 months", "12 months"], a: "4-6 months", exp: "While initial freshening occurs early, total regeneration and full results from collagen remodeling typically take 4-6 months."},
{topic: "Microneedling", q: "Microneedling is contraindicated in patients with which active skin condition?", options: ["Acne Vulgaris (non-inflammatory)", "Herpes Simplex Virus infection", "Periorbital rhytids", "Post-Inflammatory Hyperpigmentation (PIH)"], a: "Herpes Simplex Virus infection", exp: "Active infections, especially Herpes Simplex Virus, are absolute contraindications to avoid spreading the infection."},
{topic: "Microneedling", q: "Which of the following is NOT a complication associated with Microneedling?", options: ["Post-inflammatory hyperpigmentation (PIH)", "Milia-like eruption", "Needle track marks", "Acute telogen effluvium"], a: "Acute telogen effluvium", exp: "Complications include erythema/crusting, PIH, scarring/needle track marks, and flare-up of acne or Milia-like eruption. Acute telogen effluvium is a hair loss condition not typically related to Microneedling."},
{topic: "Microneedling", q: "RF Microneedling combines micro-needle penetration with which additional mechanism to induce dermal contraction?", options: ["Cryotherapy (freezing)", "High-intensity focused ultrasound (HIFU)", "Radiofrequency (RF) energy", "Pneumatic massage"], a: "Radiofrequency (RF) energy", exp: "RF Microneedling delivers RF energy directly into deep skin layers, inducing dermal contraction and stimulating collagen/elastin regeneration."},
{topic: "Microneedling", q: "In the context of combining Microneedling with topical agents, the use of electroporation serves what purpose?", options: ["Sterilization of the skin surface.", "Mechanical exfoliation of the stratum corneum.", "Increasing cell membrane permeability for transdermal product delivery.", "Reducing pain via nerve blockage."], a: "Increasing cell membrane permeability for transdermal product delivery.", exp: "Electroporation applies an electrical field to increase cell membrane permeability, facilitating the delivery of cosmetic preparations into deeper skin layers."},
{topic: "Microneedling", q: "For atrophic acne scars, what was the typical needle depth used in clinical trials utilizing a Dermaroller?", options: ["0.25 mm", "0.5 mm", "1.5 mm", "3.0 mm"], a: "1.5 mm", exp: "Clinical trials often utilize needle depths of 1.5mm for atrophic scars to penetrate the deeper dermis and initiate remodeling."},
{topic: "Microneedling", q: "Patients are advised to avoid makeup application for how long post-Microneedling procedure?", options: ["12 hours", "24 hours", "72 hours", "1 week"], a: "72 hours", exp: "Post-treatment advice includes avoiding makeup for 72 hours to prevent irritation and infection in the open micro-channels."},
{topic: "Microneedling", q: "Which of the following statements correctly describes a key advantage of the Microneedling Pen over the Microneedling Roller?", options: ["The roller is generally more sterile.", "The pen offers customizable needle depth.", "The roller has less epidermal damage.", "The pen is slower with more downtime."], a: "The pen offers customizable needle depth.", exp: "The pen allows for adjustable/customizable depth, less epidermal damage, faster treatment times, and is generally more sterile and precise than a manual roller."},
{topic: "Microneedling", q: "In the healing process, at which time point is Fibroblast proliferation noted?", options: ["Immediately post-needling", "Day 1", "Weeks 1-3", "Months 3-6"], a: "Day 1", exp: "Tissue contraction happens immediately; fibroblast proliferation begins on Day 1, followed by wound healing/collagen synthesis in Weeks 1-3."},
{topic: "Microneedling", q: "What is the typical minimum recommended course of treatment sessions for Microneedling to achieve visible results for general skin concerns?", options: ["1 session", "A minimum course of 3 sessions", "5 sessions", "10 sessions"], a: "A minimum course of 3 sessions", exp: "Generally, a minimum course of 3 sessions is recommended, with intervals and total number varying based on individual skin concerns."},
{topic: "Microneedling", q: "Which contraindication specifically relates to the use of RF Microneedling devices due to an electrical component?", options: ["Rosacea", "Pregnancy/breastfeeding", "Patient with Pacemaker", "Patient with unrealistic expectation"], a: "Patient with Pacemaker", exp: "The use of electrical/RF energy makes a Pacemaker an important contraindication for RF Microneedling systems."},
{topic: "Microneedling", q: "To effectively treat melasma, Microneedling is often combined with which type of topical treatment?", options: ["Tretinoin alone", "A depigmentation serum/Tranexamic Acid (TA)", "High-potency steroids", "Benzoyl Peroxide"], a: "A depigmentation serum/Tranexamic Acid (TA)", exp: "Studies showed significant improvement in melasma when Microneedling was combined with a depigmentation serum or Tranexamic Acid (TA) versus the topical agent alone."},
{topic: "Microneedling", q: "Microneedling combined with topical 5\\% Minoxidil showed superior results compared to Minoxidil alone for which type of alopecia?", options: ["Alopecia Areata", "Traction Alopecia", "Androgenetic Alopecia (AGA)", "Telogen Effluvium"], a: "Androgenetic Alopecia (AGA)", exp: "A prospective RCT showed mean hair counts were significantly greater in the MN + Minoxidil group compared to Minoxidil alone for Androgenetic Alopecia."},
{topic: "Microneedling", q: "Why is caution advised when deciding to use a topical anesthetic for Microneedling with needle depths greater than 1.5mm?", options: ["It slows down the healing process.", "The pain threshold may be exceeded at these depths.", "Topical anesthetics should never be used.", "It increases the risk of infection."], a: "The pain threshold may be exceeded at these depths.", exp: "If the needle depth is deeper than 1.5mm, clients with a low pain threshold are advised to apply a topical anesthetic prior to the appointment due to increased discomfort."},
{topic: "Microneedling", q: "When observing the skin's healing process after Microneedling, which change occurs first?", options: ["Collagen remodeling", "Tissue contraction through needling", "Wound healing regeneration period", "Maximum effect seen"], a: "Tissue contraction through needling", exp: "The initial, immediate response is tissue contraction through the action of the needles, followed by wound healing progress on Day 1. "},
{topic: "Microneedling", q: "Which growth factor, also known as FGF7, is critical in the epithelialization phase of wound healing?", options: ["Platelet-Derived Growth Factor (PDGF)", "Transforming Growth Factor (TGF)", "Fibroblast Growth Factor (FGF)", "Keratinocyte Growth Factor (KGF)"], a: "Keratinocyte Growth Factor (KGF)", exp: "Keratinocyte Growth Factor (KGF), or FGF7, is crucial in the epithelialization phase, binding to FGFR2b receptors on keratinocytes."},
{topic: "Microneedling", q: "The proposed benefit of using Microneedling to treat Alopecia Areata (AA) with topical corticosteroids is that MN's collagen induction counters the risk of:", options: ["Steroid-induced atrophy", "The pain associated with ILK", "The risk of keloid formation", "Hair breakage"], a: "Steroid-induced atrophy", exp: "Microneedling promotes neocollagenesis, which helps mitigate the skin atrophy known to occur with intralesional steroid injections (ILK)."},
{topic: "Microneedling", q: "Which condition can be removed using the MN pen combined with a topical agent like Bleomycin?", options: ["Milia", "Verruca (warts)", "Skin Tags", "Epidermal Cysts"], a: "Verruca (warts)", exp: "Microneedling significantly enhanced the delivery of topical Bleomycin (a chemotherapeutic agent) for treating Verruca (warts), showing high cure rates."},
{topic: "Microneedling", q: "After a Microneedling treatment, clients should avoid sun exposure and apply a daily SPF of at least:", options: ["SPF 15", "SPF 30", "SPF 50", "SPF 75"], a: "SPF 50", exp: "Clients should apply SPF 50 daily and avoid direct sun exposure due to the increased sensitivity and risk of Post-Inflammatory Hyperpigmentation (PIH)."},
{topic: "Microneedling", q: "Which depth setting is appropriate for home-use Microneedling rollers used by patients themselves?", options: ["0.1 mm", "1.0 mm", "1.5 mm", "2.0 mm"], a: "0.1 mm", exp: "Home-use rollers are limited to superficial depths (e.g., $0.1-0.25 \\text{ mm}$) for enhanced product absorption, whereas clinical treatments are much deeper. "},
{topic: "Microneedling", q: "Microneedling rollers are often criticized for which limitation compared to the pen devices?", options: ["Faster treatment times.", "Lower operator dependency.", "Slower treatment times and more operator-dependent pressure/depth.", "More sterile treatment application."], a: "Slower treatment times and more operator-dependent pressure/depth.", exp: "Rollers have slower treatment times, are operator-dependent, and generally cause more epidermal damage than pens."},
{topic: "Microneedling", q: "The immediate effect seen after a Microneedling procedure, lasting only a few days due to tissue contraction and mild swelling, is often described as:", options: ["Collagen remodeling", "Crusting/Scabbing", "Freshening of the skin", "Post-inflammatory hyperpigmentation"], a: "Freshening of the skin", exp: "The initial reaction includes tissue contraction and mild swelling, giving a temporary 'freshening' appearance, before the long-term remodeling begins."},
{topic: "Microneedling", q: "For hyperpigmentation disorders like Melasma, research suggests Microneedling combined with depigmentation serum offers enhanced delivery due to which mechanism?", options: ["Increased inflammatory response.", "Reduction of Tyrosinase enzyme.", "Creation of microchannels for transdermal delivery.", "Mechanical removal of pigment cells."], a: "Creation of microchannels for transdermal delivery.", exp: "Microneedling creates microchannels, temporarily bypassing the stratum corneum barrier, allowing better penetration of topical agents like Tranexamic Acid (TA) or Hydroquinone."},
{topic: "Microneedling", q: "Which post-treatment advice is crucial for accelerating long-term results and should be avoided for 3 days post-treatment?", options: ["Applying sunblock.", "Avoiding exfoliating products.", "Avoiding heat treatments, saunas, and intense exercise.", "Using topical antibiotics."], a: "Avoiding heat treatments, saunas, and intense exercise.", exp: "Avoiding heat/sweating for 3 days minimizes the risk of infection and severe erythema/irritation while the micro-channels close."},
{topic: "Microneedling", q: "Microneedling procedures generally cause minimal discomfort, but topical anesthetics are recommended for patients with:", options: ["High pain threshold.", "Low pain threshold or sensitive skin.", "Hyperpigmentation.", "Atrophic scars."], a: "Low pain threshold or sensitive skin.", exp: "Topical anesthetics should be made available or prescribed for clients with sensitive skin or a low pain tolerance, especially for deeper treatments."},
{topic: "Microneedling", q: "Which adverse event may occur if Microneedling is performed aggressively on a patient with Rosacea or highly sensitive skin?", options: ["Increased risk of infection.", "Paradoxical sun tanning.", "Flare-up of Rosacea or increased skin reactivity.", "Immediate volume gain."], a: "Flare-up of Rosacea or increased skin reactivity.", exp: "Active Rosacea is a contraindication because the inflammatory trauma from Microneedling can easily exacerbate the underlying condition."},
{topic: "Microneedling", q: "The healing phase spanning Weeks 1-3 is primarily characterized by which activity?", options: ["Collagen remodeling.", "Tissue contraction.", "Wound healing regeneration, featuring collagen and elastin synthesis.", "Maximum effect visibility."], a: "Wound healing regeneration, featuring collagen and elastin synthesis.", exp: "Weeks 1-3 involves the main regenerative period, characterized by collagen and elastin synthesis, before the final remodeling phase. "},
{topic: "Microneedling", q: "RF Microneedling relies on the heat generated by the RF energy to induce which effect in the tissue layers, leading to tightening?", options: ["Tissue necrosis.", "Fibrous septa contraction.", "Epidermal vaporization.", "Melanocyte destruction."], a: "Fibrous septa contraction.", exp: "The heat from the RF energy causes immediate dermal contraction and fibrous septa contraction, enhancing tightening and neocollagenesis."},
{topic: "Microneedling", q: "For a patient presenting with hyper-dynamic forehead wrinkles, what combination treatment involving Microneedling would offer the best outcome?", options: ["MN with deep chemical peel.", "MN with dermal filler.", "MN with Botulinum Neurotoxin.", "MN with intense pulsed light (IPL)."], a: "MN with Botulinum Neurotoxin.", exp: "Botulinum Neurotoxin treats the dynamic component (muscle movement) of the wrinkles, and Microneedling improves the skin texture and static lines via collagen induction."},
{topic: "Microneedling", q: "Which immediate complication must be monitored for, which may lead to scarring if Microneedling depth or technique is incorrect?", options: ["Erythema/Crusting", "Milia formation", "Needle track marks/Scarring", "Telogen Effluvium"], a: "Needle track marks/Scarring", exp: "Needle track marks and scarring are potential complications, especially when improper technique, excessive depth, or overuse is employed."},
{topic: "Microneedling", q: "In Microneedling, Platelet-Derived Growth Factor (PDGF) creates cell growth and collagen synthesis, and works synergistically with which other main growth factor family?", options: ["Glycosaminoglycans (GAGs)", "Transforming Growth Factor (TGF)", "Hyaluronidase", "Platelet Factor 4 (PF4)"], a: "Transforming Growth Factor (TGF)", exp: "PDGF and TGF are key growth factors released in the regenerative phase, collectively promoting cell growth, collagen secretion, and tissue remodeling."},
{topic: "Microneedling", q: "Which anatomical consideration is important when choosing needle depth for the treatment of hypertrophic burn scars?", options: ["Using $0.5 \\text{ mm}$ depth for epithelial stimulation.", "Using $1.0 \\text{ mm}$ depth for deep dermal penetration.", "Using $1.5 \\text{ mm}$ depth only.", "Using minimal depth as hypertrophic scars are superficial."], a: "Using $1.0 \\text{ mm}$ depth for deep dermal penetration.", exp: "Studies on hypertrophic burn scars utilized a depth of $1.0 \\text{ mm}$ with subsequent histological analysis showing increased collagen and elastin deposition."},
{topic: "Microneedling", q: "The ultimate long-term goal of Microneedling treatment, visible from Months 3-6, is referred to as:", options: ["Fibroblast Proliferation", "Epithelialization", "Collagen Remodeling", "Tissue Contraction"], a: "Collagen Remodeling", exp: "Collagen Remodeling is the final phase, resulting in the maximum improvement in skin texture, tone, and laxity."},
{topic: "Microneedling", q: "A patient reports a warming sensation immediately after the procedure. How long is this sensation expected to last?", options: ["A few days.", "A few hours.", "1 week.", "It should be immediately alarming."], a: "A few hours.", exp: "Swelling, tingling, and warmth are normal reactions that should subside over the course of a few hours, while erythema can last 1-2 days."},
{topic: "Microneedling", q: "For which skin concern is Microneedling highly effective, often surpassing the results of Minoxidil alone when used in combination?", options: ["Melasma", "Androgenetic Alopecia (AGA)", "Rosacea", "Sebaceous Hyperplasia"], a: "Androgenetic Alopecia (AGA)", exp: "The Microneedling + Minoxidil combination showed superior hair count increase compared to Minoxidil monotherapy for AGA."},
{topic: "Microneedling", q: "In the context of aesthetics, Microneedling is noted to help reduce pore size by influencing the activity of which skin structure?", options: ["Hair follicle density.", "Sebaceous glands (oil production).", "Arrector pili muscle tone.", "Eccrine sweat glands."], a: "Sebaceous glands (oil production).", exp: "Microneedling, especially combined with Radiofrequency, can help regulate sebaceous gland activity and induce collagen production around pores, leading to a reduction in pore size."},
{topic: "Microneedling", q: "Why must a client avoid exfoliating the skin or using active acid-based products for one week post-Microneedling?", options: ["To prevent severe irritation and potential infection in the healing skin.", "To maximize product absorption.", "To keep the micro-channels open longer.", "To prevent bruising."], a: "To prevent severe irritation and potential infection in the healing skin.", exp: "Exfoliating/acid products can cause severe irritation, inflammation, and complicate the healing process when the skin barrier is compromised by micro-channels."},
{topic: "Microneedling", q: "Microneedling treatments generally start showing differences in skin elasticity in as little as:", options: ["24 hours", "1 week", "1 month", "3 months"], a: "24 hours", exp: "Some clients report feeling a difference in skin elasticity as quickly as 24 hours post-treatment."},
{topic: "Microneedling", q: "Microneedling is a minimally invasive treatment used to target a variety of skin conditions on both the face and:", options: ["Scalp", "Nails", "Body", "Lips"], a: "Body", exp: "Microneedling is indicated for skin concerns on both the face and body, including treatment of scars and stretch marks on the body."},
// 3. Pain Management/Facial Anatomy - 40 Unique Questions (80 Total)
{topic: "Pain Management/Facial Anatomy", q: "Which cranial nerve's sensory branches (V1, V2, V3) are the primary targets for facial nerve blocks used in aesthetic procedures?", options: ["CN V (Trigeminal)", "CN VII (Facial)", "CN IX (Glossopharyngeal)", "CN X (Vagus)"], a: "CN V (Trigeminal)", exp: "The Trigeminal Nerve (CN V) is the primary sensory nerve of the face, and its branches (Ophthalmic V1, Maxillary V2, Mandibular V3) are targeted for regional anesthesia."},
{topic: "Pain Management/Facial Anatomy", q: "The recommended maximum dose of plain 1\\% Lidocaine (without epinephrine) for local infiltration in an average adult should not typically exceed:", options: ["100 mg", "300 mg", "500 mg", "1000 mg"], a: "300 mg", exp: "The maximum recommended dose for plain Lidocaine is approximately $4.5 \\text{ mg/kg}$, with a maximum of $300 \\text{ mg}$. Lidocaine with epinephrine max is $500 \\text{ mg}$. "},
{topic: "Pain Management/Facial Anatomy", q: "Which nerve block is most commonly used for procedures involving the upper lip, lower eyelid, lateral nose, and medial cheek?", options: ["Supraorbital Nerve Block", "Mental Nerve Block", "Infraorbital Nerve Block", "Maxillary Nerve Block"], a: "Infraorbital Nerve Block", exp: "The Infraorbital Nerve (a branch of V2) innervates most of the upper lip, lower eyelid, lateral nose, and medial cheek. "},
{topic: "Pain Management/Facial Anatomy", q: "The facial artery is typically palpable at a depression in the mandible just anterior to which muscle?", options: ["Temporalis", "Buccinator", "Masseter", "Mentalis"], a: "Masseter", exp: "The facial artery crosses the mandible just anterior to the Masseter muscle at the antegonial notch, where it is palpable and should be protected during jawline injections."},
{topic: "Pain Management/Facial Anatomy", q: "Local anesthetics primarily achieve anesthesia by blocking the action of which ion channel in the neural cell membrane?", options: ["Potassium channels", "Calcium channels", "Voltage-gated Sodium channels", "Chloride channels"], a: "Voltage-gated Sodium channels", exp: "Injectable Lidocaine reduces pain by blocking voltage-gated Sodium channels and inhibiting impulse propagation. Smaller fibers (pain/temp) are blocked first."},
{topic: "Pain Management/Facial Anatomy", q: "Which advantage do Regional Nerve Blocks offer over Local Infiltration in aesthetic procedures?", options: ["They have a faster onset of action.", "They cause more tissue edema and distortion.", "They require a smaller amount of anesthetic and do not distort tissue anatomy.", "They are superior for highly vascular areas."], a: "They require a smaller amount of anesthetic and do not distort tissue anatomy.", exp: "Nerve Blocks minimize discomfort with less anesthetic volume and prevent tissue distortion, which is crucial for precise filler placement."},
{topic: "Pain Management/Facial Anatomy", q: "The flattening of the dermal-epidermal junction and reduced thickness of the dermis are listed as effects of what process?", options: ["Rosacea", "Acne", "Aging: Integument", "Phytophotodermatitis"], a: "Aging: Integument", exp: "These are primary structural changes associated with skin aging, along with degeneration of elastic fibers and loss of subcutaneous adipose tissue. "},
{topic: "Pain Management/Facial Anatomy", q: "In the Skin Anatomy, the thick collagen fibers running parallel to the surface, along with hair follicles, sebaceous, and apocrine glands, are characteristic of which layer?", options: ["Epidermis", "Papillary (upper) Dermis", "Reticular (deep) Dermis", "Hypodermis"], a: "Reticular (deep) Dermis", exp: "The Reticular Dermis is the deep layer providing structural integrity, containing thick, parallel collagen fibers, and accessory appendages. [Image of the skin cross-section]"},
{topic: "Pain Management/Facial Anatomy", q: "Which type of nociceptive pain is generally felt as a sharp pain, dull ache, or throbbing sensation, detected by nerves in the skin, subcutaneous tissues, muscles, and joints?", options: ["Referred pain", "Neuropathic pain", "Somatic pain", "Visceral pain"], a: "Somatic pain", exp: "Somatic pain originates in the skin, muscle, and joints. Visceral pain originates in internal organs and can be referred."},
{topic: "Pain Management/Facial Anatomy", q: "The Facial Nerve (CN VII) is primarily known for controlling which function?", options: ["Sensory innervation of the face.", "Motor control of the muscles of mastication.", "Motor control of the muscles of facial expression.", "Special sensory to the posterior $1/3$ of the tongue."], a: "Motor control of the muscles of facial expression.", exp: "The Facial Nerve (CN VII) is responsible for the motor control of all muscles of facial expression. [Image of the muscles of facial expression]"},
{topic: "Pain Management/Facial Anatomy", q: "The supraorbital foramen, where the nerve exits for a nerve block, is located directly over which anatomical landmark?", options: ["The medial canthus", "The lateral canthus", "The pupil", "The ala of the nose"], a: "The pupil", exp: "The supraorbital foramen (or notch) is located directly over the pupil in most individuals. The block is used for regional anesthesia of the forehead."},
{topic: "Pain Management/Facial Anatomy", q: "Which facial danger zone for filler injection is specifically associated with the Supra-trochlear artery?", options: ["Temple", "Nose", "Infraorbital Region", "Glabella"], a: "Glabella", exp: "The Glabella is a critical danger zone, associated with the Supra-trochlear artery, where occlusive injection poses a high risk of blindness. "},
{topic: "Pain Management/Facial Anatomy", q: "In the sequence of nociceptive pain phases, which phase involves the brain becoming aware or conscious of the pain?", options: ["Transduction", "Transmission", "Perception", "Modulation"], a: "Perception", exp: "Perception is the phase where the electrical signal reaches the cerebral cortex and the person becomes aware of the pain."},
{topic: "Pain Management/Facial Anatomy", q: "What is the primary purpose of buffering injectable lidocaine with sodium bicarbonate in a 1:8 or 1:10 ratio?", options: ["To increase its potency and duration.", "To reduce the burning sensation upon injection.", "To decrease the risk of systemic toxicity.", "To prolong the effect of epinephrine."], a: "To reduce the burning sensation upon injection.", exp: "Buffering increases the $\\text{pH}$ of the acidic lidocaine solution, making it closer to physiologic $\\text{pH}$ and minimizing the patient's pain upon injection."},
{topic: "Pain Management/Facial Anatomy", q: "For a Mandibular Nerve Block, the needle is typically inserted parallel to an imaginary line drawn from the intertragic notch to which facial feature?", options: ["The apex of the nose", "The corner of the mouth (angle of the mouth)", "The lateral orbital rim", "The zygomatic arch"], a: "The corner of the mouth (angle of the mouth)", exp: "The Mandibular Nerve Block (Gow-Gates approach) is inserted high, parallel to the line drawn from the intertragic notch to the angle of the mouth."},
{topic: "Pain Management/Facial Anatomy", q: "Which major artery supplies blood to the face and is a branch of the Internal Carotid Artery (ICA)?", options: ["Facial artery", "Maxillary artery", "Superficial temporal artery", "Supra-orbital artery"], a: "Supra-orbital artery", exp: "The Supra-orbital artery is a branch of the Ophthalmic artery, which is a branch of the ICA. The others are branches of the External Carotid Artery (ECA). "},
{topic: "Pain Management/Facial Anatomy", q: "The typical onset of anesthetic effect for an Infraorbital Nerve Block after injection is:", options: ["Immediate (within seconds)", "1 to 2 minutes", "5 to 10 minutes", "Over 30 minutes"], a: "5 to 10 minutes", exp: "Regional nerve blocks, including the Infraorbital Nerve Block, typically require 5 to 10 minutes for the anesthetic to fully diffuse and achieve its effect."},
{topic: "Pain Management/Facial Anatomy", q: "The total skin thickness on the face (Epidermis + Dermis) typically measures:", options: ["$0.35 \\text{ mm}$ to $1.1 \\text{ mm}$", "$2 \\text{ mm}$ to $4 \\text{ mm}$", "$5 \\text{ mm}$ to $10 \\text{ mm}$", "$10 \\text{ mm}$ to $20 \\text{ mm}$"], a: "$0.35 \\text{ mm}$ to $1.1 \\text{ mm}$", exp: "Skin thickness varies: Eyelids ($0.35 \\text{ mm}$ total), Face ($0.6-1.1 \\text{ mm}$ total), Back ($2-4 \\text{ mm}$ Dermis)."},
{topic: "Pain Management/Facial Anatomy", q: "Which area of the Maxillary Nerve (V2) is difficult to anesthetize completely with an Infraorbital Nerve Block alone, often requiring supplementary local infiltration?", options: ["Lateral cheek", "Lower eyelid", "Philtrum and corners of the mouth", "Lateral nose"], a: "Philtrum and corners of the mouth", exp: "The Philtrum and corners of the mouth are poorly anesthetized by the Infraorbital Block alone and require additional intraoral infiltration."},
{topic: "Pain Management/Facial Anatomy", q: "What is the consequence if the Maxillary Nerve (V2) is blocked (Maxillary Nerve Block)?", options: ["Motor paralysis of the entire face.", "Anesthesia of the orbit, lateral nose, cheek, and upper teeth/lip.", "Anesthesia only of the lower jaw.", "Temporary blindness."], a: "Anesthesia of the orbit, lateral nose, cheek, and upper teeth/lip.", exp: "The Maxillary Nerve (V2) block anesthetizes a wide area: the orbit, lateral nose, cheek, upper gum, palate, teeth, and upper lip."},
{topic: "Pain Management/Facial Anatomy", q: "The superficial temporal artery and vein are danger zones when injecting which anatomical region for aesthetic purposes?", options: ["Glabella", "Infraorbital Region", "Temple", "Nose"], a: "Temple", exp: "The Temple is a danger zone due to the presence of the superficial temporal artery and vein. Injection should be placed deep to the artery or superiorly/posteriorly to the brow. "},
{topic: "Pain Management/Facial Anatomy", q: "Which type of local anesthetic (e.g., Tetracaine + Epinephrine) is an excellent choice for ENT procedures due to its natural vasoconstrictive properties?", options: ["Lidocaine", "Cocaine", "Bupivacaine", "Procaine"], a: "Cocaine", exp: "Cocaine is an excellent topical anesthetic for ENT due to its strong vasoconstriction of vessels, limiting bleeding, though Tetracaine/Epinephrine is a modern alternative."},
{topic: "Pain Management/Facial Anatomy", q: "The deepest layer of skin shown in the cross-section, primarily composed of adipose tissue and containing the Pacinian corpuscle, is the:", options: ["Epidermis", "Dermis", "Hypodermis", "Papillary Layer"], a: "Hypodermis", exp: "The Hypodermis (subcutaneous fat) is the deepest layer, housing adipose tissue, eccrine sweat glands, and sensory nerve fibers/corpuscles. [Image of skin layers]"},
{topic: "Pain Management/Facial Anatomy", q: "What should be avoided during a Mental Nerve Block to prevent potential damage or numbness to the mandible and anterior teeth?", options: ["Inserting the needle along the lower gum line.", "Retracting the cheek laterally.", "Injecting directly into the mental foramen.", "Using a large volume of anesthetic."], a: "Injecting directly into the mental foramen.", exp: "The needle should not be placed directly into the mental foramen. The anesthetic should be deposited around the foramen (buccal fold) to block the nerve as it exits."},
{topic: "Pain Management/Facial Anatomy", q: "The muscle responsible for frowning and creating the vertical glabellar lines is the:", options: ["Frontalis", "Procerus", "Corrugator Supercilii", "Orbicularis Oculi"], a: "Corrugator Supercilii", exp: "The Corrugator Supercilii muscle pulls the eyebrow medially and inferiorly, producing the vertical '11' lines."},
{topic: "Pain Management/Facial Anatomy", q: "What is the classification name for the 14 bones that form the front and lower parts of the skull, including the mandible and maxilla?", options: ["Neurocranium", "Viscerocranium", "Calvaria", "Cranial vault"], a: "Viscerocranium", exp: "The skull is divided into the Neurocranium (8 cranial bones) and the Viscerocranium (14 facial bones). "},
{topic: "Pain Management/Facial Anatomy", q: "The danger zone in the Nose for filler injection is critical because a misplaced injection can lead to disastrous results such as tip and alar necrosis, ocular ischemia, and:", options: ["Permanent facial paralysis.", "Severe anaphylaxis.", "Blindness.", "Mandibular nerve damage."], a: "Blindness.", exp: "The shallow vasculature and connection to the ophthalmic artery make the nose a high-risk area for vascular occlusion leading to blindness. "},
{topic: "Pain Management/Facial Anatomy", q: "Which is the most appropriate action if severe pain or burning occurs during a local anesthetic infiltration?", options: ["Continue the injection slowly.", "Assume it is normal and increase the injection speed.", "Stop and immediately withdraw the needle.", "Stop, assume extravasation, and inject saline to dilute the anesthetic."], a: "Stop and immediately withdraw the needle.", exp: "Severe pain is often a sign of extravasation or intraneural injection. The immediate action is to stop and withdraw the needle."},
{topic: "Pain Management/Facial Anatomy", q: "Lidocaine with epinephrine is typically preferred for local infiltration in aesthetic procedures primarily because the epinephrine provides:", options: ["Increased sensory nerve block activity.", "Vasoconstriction and reduced risk of bruising.", "Longer duration of action (over 8 hours).", "Enhanced lymphatic drainage."], a: "Vasoconstriction and reduced risk of bruising.", exp: "Epinephrine causes vasoconstriction, which minimizes bleeding and bruising, and also prolongs the local anesthetic's duration by reducing systemic absorption."},
{topic: "Pain Management/Facial Anatomy", q: "The layer of the epidermis that is highly cornified, composed of many layers of keratinized dead cells, and serves as the outermost protective layer is the:", options: ["Stratum Basale", "Stratum Spinosum", "Stratum Granulosum", "Stratum Corneum"], a: "Stratum Corneum", exp: "The Stratum Corneum (horny cell layer) is the outermost, dead, keratinized layer. "},
{topic: "Pain Management/Facial Anatomy", q: "Which danger zone is characterized by the need to inject at least $2 \\text{ cm}$ above the superior border of the zygoma and posteriorly from the tail of the brow to avoid major vessels?", options: ["Infraorbital Region", "Lips", "Temple", "Nasolabial Fold"], a: "Temple", exp: "This anatomical rule helps avoid the superficial temporal artery and middle temporal vein in the Temple region. "},
{topic: "Pain Management/Facial Anatomy", q: "The two-step injection required for the Infraorbital Nerve Block (Infraorbital Nerve Block + additional infiltration) is needed to adequately anesthetize which specific region?", options: ["Maxillary teeth", "Lateral cheek", "Corners of the mouth and philtrum", "Lower eyelid"], a: "Corners of the mouth and philtrum", exp: "The Infraorbital Nerve Block often poorly anesthetizes the philtrum and mouth corners, requiring a supplemental intraoral infiltration near the upper lip frenulum."},
{topic: "Pain Management/Facial Anatomy", q: "Which statement is true regarding the use of a eutectic mixture of local anesthetics (EMLA: Lidocaine $2.5\\%$ + Prilocaine $2.5\\%$)?", options: ["Onset is immediate and lasts 1 hour.", "It is contraindicated in pediatrics.", "Onset is 30 minutes and lasts 3-5 hours.", "It must be injected deeply intramuscularly."], a: "Onset is 30 minutes and lasts 3-5 hours.", exp: "EMLA is a topical cream widely used in pediatrics and dermatology, with an onset of 30 minutes and a duration of 3-5 hours."},
{topic: "Pain Management/Facial Anatomy", q: "What part of the Trigeminal Nerve (CN V) is primarily motor, controlling the muscles of mastication?", options: ["Ophthalmic Nerve (V1)", "Maxillary Nerve (V2)", "Mandibular Nerve (V3)", "Facial Nerve (CN VII)"], a: "Mandibular Nerve (V3)", exp: "The Mandibular Nerve (V3) is the only branch of the Trigeminal Nerve with a motor component, controlling the muscles of mastication (masseter, temporalis, pterygoids). [Image of the Trigeminal nerve branches]"},
{topic: "Pain Management/Facial Anatomy", q: "When performing a Supraorbital Nerve Block, the needle is inserted sub-cutaneously and directed along the brow to avoid damaging which underlying structure?", options: ["The Zygomatic arch.", "The orbital rim.", "The bone (periosteum) level.", "The pupil itself."], a: "The bone (periosteum) level.", exp: "The technique involves inserting the needle $s/q$ lateral to medial, *above* the bone level, with aspiration prior to injection, to place the anesthetic near the nerve without direct trauma."},
{topic: "Pain Management/Facial Anatomy", q: "The danger zone in the Lips for filler injection is located where the superior labial artery runs posterior to which anatomical boundary?", options: ["The skin-muscle interface.", "The inferior border of the mandible.", "The labiomental crease.", "The mental foramen."], a: "The skin-muscle interface.", exp: "The superior labial artery typically runs posterior to the mucosa-muscle interface. Low G' fillers at the vermilion cutaneous border (no more than $3 \\text{ mm}$ deep) are recommended. "},
{topic: "Pain Management/Facial Anatomy", q: "Which is a mechanism of pain modulation, where chemicals like endorphins and serotonin are released by the brain to alter the pain experience?", options: ["Transduction", "Transmission", "Perception", "Modulation"], a: "Modulation", exp: "Modulation is the final phase where the brain interacts with nerves to adjust the intensity and duration of the pain experience."},
{topic: "Pain Management/Facial Anatomy", q: "The Mandibular Nerve Block typically results in anesthesia of which areas?", options: ["Upper teeth, upper lip, and orbit.", "Ipsilateral mandibular teeth, lower lip, and floor of the mouth.", "Entire cheek and lateral nasal wall.", "All muscles of facial expression."], a: "Ipsilateral mandibular teeth, lower lip, and floor of the mouth.", exp: "The Mandibular Nerve (V3) block anesthetizes the entire lower ipsilateral jaw (teeth, gums, chin, and lower lip) except for the angle of the jaw."},
{topic: "Pain Management/Facial Anatomy", q: "The deepest plane of filler placement, directly onto the bone to imitate a surgical implant and provide lift to the overlying tissue, is referred to as:", options: ["Intradermal", "Subcutaneous", "Supraperiosteal", "Intramuscular"], a: "Supraperiosteal", exp: "Supraperiosteal injection (layer 4) places material deep onto the bone, utilizing an avascular plane for maximal projection and minimal edema."},
{topic: "Pain Management/Facial Anatomy", q: "Which type of pain is detected by nociceptors in the body's internal organs and may be associated with nausea, vomiting, or be felt further away from its actual origin?", options: ["Somatic pain", "Referred pain/Visceral pain", "Neuropathic pain", "Phantom pain"], a: "Referred pain/Visceral pain", exp: "Visceral pain originates in the viscera (internal organs) and can manifest as referred pain, often accompanied by systemic symptoms like nausea."},
// 4. Sclerotherapy - 40 Unique Questions (80 Total)
{topic: "Sclerotherapy", q: "Venulectasias are classified as blue, sometimes distended vessels smaller than which maximum diameter?", options: ["$<0.5 \\text{ mm}$", "$<1 \\text{ mm}$", "$<2 \\text{ mm}$", "$<4 \\text{ mm}$"], a: "$<2 \\text{ mm}$", exp: "Venulectasias are blue vessels smaller than $2 \\text{ mm}$. Telangiectasias are red vessels $<1 \\text{ mm}$, and reticular veins are $2-4 \\text{ mm}$ (cyanotic hue)."},
{topic: "Sclerotherapy", q: "What is the primary mechanism of action of Sodium Tetradecyl Sulfate (STS) when used as a sclerosing agent?", options: ["Osmotic dehydration of the cell wall.", "Direct caustic destruction of the endothelium.", "Disruption of the vein cellular membrane (Detergent).", "Vasoconstriction."], a: "Disruption of the vein cellular membrane (Detergent).", exp: "STS (Sotradecol) and Polidocanol are detergent sclerosants that disrupt the endothelial cell membrane by 'protein theft denaturation.'"},
{topic: "Sclerotherapy", q: "Which is listed as a major contraindication for Sclerotherapy?", options: ["Post-partum period", "Obesity", "Hypercoagulable states", "Family history of varicose veins"], a: "Hypercoagulable states", exp: "Hypercoagulable states, thrombophlebitis, pulmonary emboli, and pregnancy are major contraindications due to the risk of deep vein thrombosis (DVT)."},
{topic: "Sclerotherapy", q: "What is the recommended approach to treating multiple veins in a single session?", options: ["Treat only the smallest vessels first.", "Treat all vessels simultaneously in a cross-hatch pattern.", "Treat proximal sites of reflux and larger veins before smaller vessels.", "Only treat telangiectasias directly without treating reticular veins."], a: "Treat proximal sites of reflux and larger veins before smaller vessels.", exp: "The basic principle is to eliminate the source of reflux first (proximal source) and treat the flow from large to small veins (truncal $\\rightarrow$ reticular $\\rightarrow$ telangiectasias)."},
{topic: "Sclerotherapy", q: "Which sclerosant is an osmotic agent that damages the cell by shifting the water balance, often causing pain/burning upon injection?", options: ["Polidocanol", "Sodium Tetradecyl Sulfate (STS)", "Hypertonic Sodium Chloride Solution (HSS)", "Ethanolamine Oleate"], a: "Hypertonic Sodium Chloride Solution (HSS)", exp: "HSS is an osmotic agent. Its key drawbacks include pain/burning, risk of tissue necrosis if extravasated, and increased chance of postsclerotherapy hemosiderin staining."},
{topic: "Sclerotherapy", q: "The use of foam sclerotherapy is generally reserved for which application?", options: ["Treating fine telangiectasias ($<1 \\text{ mm}$)", "Treating deep venous thrombosis (DVT)", "Treating larger vessels (like varicose veins)", "Treating facial spider veins"], a: "Treating larger vessels (like varicose veins)", exp: "Foam (sclerosant mixed with a gas) is effective in larger vessels because it pushes blood out and increases contact with the vein wall, minimizing dilution."},
{topic: "Sclerotherapy", q: "What is the typical compression stocking strength (in $\\text{mmHg}$) recommended post-Sclerotherapy for most patients?", options: ["$8-15 \\text{ mmHg}$", "$15-20 \\text{ mmHg}$", "$20-30 \\text{ mmHg}$", "$40-50 \\text{ mmHg}$"], a: "$20-30 \\text{ mmHg}$", exp: "Class I ($20-30 \\text{ mmHg}$) or Class II ($30-40 \\text{ mmHg}$) stockings are worn for $1-3$ weeks to reduce complications like edema and hyperpigmentation."},
{topic: "Sclerotherapy", q: "What is the appropriate action if a porcelain white blanching (early sign of arteriolar injection or spasm) develops during Sclerotherapy?", options: ["Wait 30 minutes to see if it resolves spontaneously.", "Apply immediate compression and continue the injection at a different site.", "Stop the injection and apply topical nitroglycerin ointment or massage.", "Immediately inject more sclerosant to dilute the concentration."], a: "Stop the injection and apply topical nitroglycerin ointment or massage.", exp: "Porcelain white blanching indicates arterial compromise (spasm or injection). The injection must stop immediately, and intervention (massage/nitroglycerin) is needed to induce vasodilation."},
{topic: "Sclerotherapy", q: "What is the recommended time interval between follow-up treatment sessions for the same anatomical locations?", options: ["1 week", "$2-8$ weeks", "3 months", "6 months"], a: "$2-8$ weeks", exp: "Treatment sessions for the same anatomical location are typically spaced at intervals of $2-8$ weeks to allow for vessel clearance and assessment of results."},
{topic: "Sclerotherapy", q: "Which imaging study is primarily used to guide Sclerotherapy injections (Endovenous Chemical Ablation) into truncal veins?", options: ["X-ray venography", "CT venography", "Duplex ultrasonography", "MRI venography"], a: "Duplex ultrasonography", exp: "Duplex ultrasonography is mandatory for larger vessels to visualize anatomy, assess reflux (functional impairment), and guide the needle/sclerosant placement."},
{topic: "Sclerotherapy", q: "The development of corona phlebectasia (dense cluster of medial malleolar telangiectasias) is typically seen in longstanding reflux of which vein?", options: ["Small Saphenous Vein (SSV)", "Peroneal Vein", "Great Saphenous Vein (GSV)", "Femoral Vein"], a: "Great Saphenous Vein (GSV)", exp: "Corona phlebectasia is a key cutaneous manifestation seen in long-standing Great Saphenous Vein (GSV) reflux, indicating chronic venous hypertension."},
{topic: "Sclerotherapy", q: "What complication often results from extravasation of a high volume or high concentration of a sclerosant during treatment?", options: ["Superficial thrombophlebitis", "Tissue necrosis", "Hyperpigmentation", "Telangiectatic matting"], a: "Tissue necrosis", exp: "Tissue necrosis is often the result of extravasation or accidental injection into an arteriole, and is the leading cause of malpractice claims in sclerotherapy."},
{topic: "Sclerotherapy", q: "In the pathophysiology of varicose veins, valve leaflets do not expand, leading to a back-flow known as:", options: ["Dermatitis", "Reflux (Secondary Valvular Incompetence)", "Thrombosis", "Arterial Occlusion"], a: "Reflux (Secondary Valvular Incompetence)", exp: "Changes in vein wall (overstretching) lead to secondary valvular incompetence and reflux, causing blood pooling and subsequent varicosity formation."},
{topic: "Sclerotherapy", q: "Which statement is true regarding the use of Hypertonic Sodium Chloride Solution (HSS) as a sclerosant?", options: ["It does not produce tissue necrosis if extravasated.", "It is the most widely accepted sclerosant worldwide.", "Its use in sclerotherapy is considered 'off-label' by the US FDA.", "It is often painless upon injection."], a: "Its use in sclerotherapy is considered 'off-label' by the US FDA.", exp: "HSS is FDA-approved for other uses, but its use specifically for sclerotherapy remains 'off-label.'"},
{topic: "Sclerotherapy", q: "Telangiectatic matting, a complication of sclerotherapy, is defined as the appearance of:", options: ["Hyperpigmentation along the treated vessel.", "Immediate bruising and swelling at the injection site.", "A dense network of fine, new vessels.", "A hard, thrombosed vessel segment."], a: "A dense network of fine, new vessels.", exp: "Telangiectatic matting is neovascularization (the development of a dense cluster of new, fine vessels) often observed around the treated area."},
{topic: "Sclerotherapy", q: "Which category of sclerosant includes Sodium morrhuate and Ethanolamine Oleate, achieving destruction by a direct caustic effect on the endothelium?", options: ["Detergents", "Osmotic agents", "Chemical irritants", "Solvents"], a: "Chemical irritants", exp: "Chemical irritants achieve destruction through a direct caustic effect on the endothelium. The primary modern agents (STS, Polidocanol) are detergents."},
{topic: "Sclerotherapy", q: "In cases of severe extravasation of a large volume or high concentration of a sclerosant, immediate treatment with which substance is advisable?", options: ["Normal Sodium Chloride Solution", "Hyaluronidase", "Adrenaline (Epinephrine)", "Topical Nitroglycerin Paste"], a: "Hyaluronidase", exp: "Immediate injection of Hyaluronidase is advisable to dilute and hydrolyze the sclerosing agent, minimizing tissue damage. Non-specific agents like saline are less effective."},
{topic: "Sclerotherapy", q: "Which condition, if present, should be addressed first before proceeding with the treatment of visible varicosities or telangiectasias?", options: ["A cosmetic vein on the ankle.", "An incompetent saphenofemoral junction (proximal reflux).", "A small reticular vein.", "A non-healing ulcer."], a: "An incompetent saphenofemoral junction (proximal reflux).", exp: "Failure to treat the source of reflux (like an incompetent saphenofemoral or saphenopopliteal junction) often leads to recurrence of distal veins."},
{topic: "Sclerotherapy", q: "Which region has the highest propensity for ulceration following sclerotherapy and thus requires limited treatment in each session?", options: ["Inner knee and thigh.", "Pretibial area and ankle skin.", "Gastrocnemius region.", "Popliteal fossa."], a: "Pretibial area and ankle skin.", exp: "The pretibial area and ankle skin are thin, have less subcutaneous tissue, and thus have the highest risk of ulceration if extravasation occurs."},
{topic: "Sclerotherapy", q: "The use of compression socks (e.g., $20-30 \\text{ mmHg}$) post-sclerotherapy has been shown to enhance efficacy primarily by:", options: ["Eliminating the risk of deep vein thrombosis.", "Improving clinical vessel disappearance.", "Preventing allergic reactions.", "Reducing the necessary concentration of the sclerosant."], a: "Improving clinical vessel disappearance.", exp: "Compression enhances efficacy by reducing postsclerotherapy thrombosis/inflammation and improving clinical vessel disappearance, while also decreasing edema and hyperpigmentation."},
{topic: "Sclerotherapy", q: "The term for when a solution is injected into a vein, causing it to collapse, scar, and fade, is known as:", options: ["Ambulatory Phlebectomy", "Endovenous Laser Ablation (EVLA)", "Sclerotherapy (Endovenous Chemical Ablation)", "Venous Ligation"], a: "Sclerotherapy (Endovenous Chemical Ablation)", exp: "Sclerotherapy is the minimally invasive chemical process used to eradicate unwanted small vessels. "},
{topic: "Sclerotherapy", q: "Which class of sclerosants, including Chromated Glycerin and Polyiodinated Iodine, achieve cell wall damage by direct caustic destruction of the endothelium?", options: ["Osmotic agents", "Detergents", "Chemical irritants", "Solvents"], a: "Chemical irritants", exp: "Chemical irritants cause direct endothelial destruction; they are less commonly used than modern detergent agents."},
{topic: "Sclerotherapy", q: "Before treating lower extremity veins, a detailed review of which anatomical system is considered essential due to its complexity and variability?", options: ["The muscular system.", "The superficial venous system (saphenous).", "The arterial system.", "The lymphatic system."], a: "The superficial venous system (saphenous).", exp: "The superficial system, including the Great and Short Saphenous Veins and their tributaries, is highly complex and variable, requiring a thorough review before injection. [Image of lower leg vein anatomy]"},
{topic: "Sclerotherapy", q: "Polidocanol is considered advantageous because it is a non-ester local anesthetic and carries a very low incidence of:", options: ["Hemosiderin staining.", "Tissue necrosis upon extravasation.", "Allergic reactions.", "Hyperpigmentation."], a: "Allergic reactions.", exp: "Polidocanol has a very low incidence of allergic reactions compared to some other agents, is virtually painless, and typically does not cause tissue necrosis if extravasation."},
{topic: "Sclerotherapy", q: "A rare but serious complication of Sclerotherapy that includes symptoms like hives, swelling of the lips/tongue, difficulty breathing, and hypotension is:", options: ["Superficial Thrombophlebitis", "Allergic Reaction/Anaphylaxis", "Telangiectatic Matting", "Postsclerotherapy Edema"], a: "Allergic Reaction/Anaphylaxis", exp: "Severe allergic reactions/anaphylaxis, although rare ($0.3\\%$), can occur with any sclerosant and require immediate attention. [Image of allergic reaction symptoms]"},
{topic: "Sclerotherapy", q: "Which vessel diameter is typically classified as a Telangiectasia?", options: ["$<1 \\text{ mm}$ (flat, red)", "$1-2 \\text{ mm}$ (blue)", "$2-4 \\text{ mm}$ (cyanotic hue)", "$>4 \\text{ mm}$ (varicose)"], a: "$<1 \\text{ mm}$ (flat, red)", exp: "Telangiectasias are defined as flat, red vessels smaller than $1 \\text{ mm}$ in diameter."},
{topic: "Sclerotherapy", q: "What should be the maximum volume injected per site during Sclerotherapy, at intervals of $2-3 \\text{ cm}$, to minimize adverse effects?", options: ["$0.01 \\text{ ml}$ to $0.05 \\text{ ml}$", "$0.1 \\text{ ml}$ to $0.4 \\text{ ml}$", "$1.0 \\text{ ml}$ to $2.0 \\text{ ml}$", "$5.0 \\text{ ml}$ or more"], a: "$0.1 \\text{ ml}$ to $0.4 \\text{ ml}$", exp: "Small injection volumes ($0.1-0.4 \\text{ ml}$) and low injection pressure minimize telangiectatic matting and ulceration risk."},
{topic: "Sclerotherapy", q: "What distinguishes Superficial Thrombophlebitis from Deep Vein Thrombosis (DVT) as a complication?", options: ["ST is more common in large vessels and managed conservatively.", "DVT is always asymptomatic.", "ST requires immediate anticoagulation.", "ST is managed with surgical excision only."], a: "ST is more common in large vessels and managed conservatively.", exp: "Superficial Thrombophlebitis is usually localized, more common in large vessels, and typically treated conservatively with compression and NSAIDs, whereas DVT is a life-threatening event."},
{topic: "Sclerotherapy", q: "Which sclerosant typically uses concentrations of $0.5\\%-1.0\\%$ for reticular veins ($2-4 \\text{ mm}$) and $0.25\\%-0.75\\%$ for telangiectasias ($<1 \\text{ mm}$)?", options: ["Hypertonic Saline (HSS)", "Sodium Morrhuate", "Polidocanol", "Ethanolamine Oleate"], a: "Polidocanol", exp: "Polidocanol concentrations vary by vessel size, starting lower ($0.25\\%$) for telangiectasias and increasing up to $1.0\\%$ for reticular veins."},
{topic: "Sclerotherapy", q: "If a patient experiences severe extravasation of a sclerosant, what specific substance should be injected immediately to dilute and neutralize the agent?", options: ["Normal Sodium Chloride Solution", "Hyaluronidase", "Adrenaline (Epinephrine)", "Topical Nitroglycerin Paste"], a: "Hyaluronidase", exp: "Immediate injection of Hyaluronidase is advisable to dilute and hydrolyze the sclerosing agent, minimizing tissue damage. Non-specific agents like saline are less effective."},
{topic: "Sclerotherapy", q: "In the final treatment of smaller vessels, what is noted as a difficult outcome pattern?", options: ["Adequately treated telangiectasia rarely recur.", "Most recurrences are in fact new vessels.", "Reticular veins are sometimes more fragile than associated telangiectasia.", "All of the above."], a: "All of the above.", exp: "All these points reflect the challenges in achieving optimal long-term results for small vessel sclerotherapy, which requires a nuanced, individualized approach."},
{topic: "Sclerotherapy", q: "Before a Sclerotherapy treatment, a physician should review which pre-operative medications due to their effect on bleeding or inflammation?", options: ["Statins, ACE inhibitors, and Beta-blockers.", "Hormone replacement, aspirin, NSAIDs, and Vitamin E.", "Thyroid medications and anti-depressants.", "Immunosuppressants and muscle relaxants."], a: "Hormone replacement, aspirin, NSAIDs, and Vitamin E.", exp: "Aspirin, NSAIDs, and Vitamin E affect platelet function or increase bruising. Hormone Replacement Therapy (HRT) may contribute to venous issues."},
{topic: "Sclerotherapy", q: "What mechanical advantage does mixing a detergent sclerosing agent with a gas (e.g., air) to form foam provide?", options: ["Decreased allergic potential.", "Increased sclerosant concentration.", "Lack of dilution with blood and homogeneous contact along the injected veins.", "Increased pain upon injection."], a: "Lack of dilution with blood and homogeneous contact along the injected veins.", exp: "Foam displaces blood effectively and allows the sclerosant to contact the vein wall more uniformly than liquid, requiring a smaller volume."},
{topic: "Sclerotherapy", q: "What is the consequence of not achieving adequate closure after injection of a large vessel?", options: ["Hyperpigmentation.", "Superficial thrombophlebitis.", "Recurrence of the treated vein.", "Telangiectatic matting."], a: "Superficial thrombophlebitis.", exp: "In large vessels, inadequate closure can lead to superficial thrombophlebitis (painful inflammation/thrombosis of the segment) or the vein's reappearance."},
{topic: "Sclerotherapy", q: "The goal of Sclerotherapy is to eradicate unwanted small vessels. These small vessels include telangiectasias, venulectasias, and:", options: ["Varicose veins ($>4 \\text{ mm}$)", "Deep perforating veins.", "Reticular ectasias ($2-4 \\text{ mm}$)", "Saphenous veins."], a: "Reticular ectasias ($2-4 \\text{ mm}$)", exp: "Small vessel disease targeted by visual sclerotherapy includes telangiectasias ($<1 \\text{ mm}$), venulectasias ($<2 \\text{ mm}$), and reticular veins ($2-4 \\text{ mm}$)."},
{topic: "Sclerotherapy", q: "Which vein diameter classification is described as having a 'cyanotic hue' and typically measures $2-4 \\text{ mm}$ in diameter?", options: ["Telangiectasias", "Venulectasias", "Reticular veins", "Varicosities"], a: "Reticular veins", exp: "Reticular veins are the sub-dermal cyanotic-hued feeding vessels, intermediate in size between telangiectasias and true varicosities."},
{topic: "Sclerotherapy", q: "Why is a single treatment session often insufficient for complete clearance of spider veins?", options: ["Due to the development of allergic reactions.", "Because only a fraction of the micro-vessels are treated per session and new vessels may develop.", "Because the sclerosant is metabolized too quickly.", "Due to patient non-compliance with compression."], a: "Because only a fraction of the micro-vessels are treated per session and new vessels may develop.", exp: "Sclerotherapy typically requires multiple treatment sessions due to the number of veins and the development of new, small vessels over time (neovascularization/matting)."},
// 5. Combined Treatments & Dermal Filler Basics - 40 Unique Questions (80 Total)
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which statement is the main benefit of combining a PDO thread lift with dermal fillers?", options: ["It provides a permanent, surgical lift.", "It allows simultaneous lifting and volumizing for more comprehensive results.", "It eliminates the need for anesthesia.", "It replaces the need for a second treatment session."], a: "It allows simultaneous lifting and volumizing for more comprehensive results.", exp: "Combined procedures provide synergistic results, restoring youthful contours by addressing both lifting (threads) and volume loss (fillers) concurrently."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The immediate mechanical lift achieved by a PDO thread lift is followed by a biological effect of stimulating the natural production of what substance in the ensuing months?", options: ["Elastin only", "Subcutaneous fat", "Collagen", "Vascular endothelial growth factor (VEGF)"], a: "Collagen", exp: "The long-term biological effect of PDO (Polydioxanone) threads is collagen stimulation (neocollagenesis) around the dissolving suture."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which filler material is considered 'temporary' due to its bovine or human cell origin and has the shortest effect duration (approx. $3-4$ months)?", options: ["Poly-L-Lactic Acid (PLLA)", "Hyaluronic Acid (HA)", "Collagen", "Polymethylmethacrylate (PMMA)"], a: "Collagen", exp: "Collagen fillers (e.g., Zyderm, Zyplast) are bioresorbable and shortest-acting ($3-4$ months)."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which type of thread lift uses cones or barbs (cogs) along the suture to mechanically elevate and compress tissue?", options: ["Mono threads", "Screw threads", "Cog threads", "Smooth threads"], a: "Cog threads", exp: "Cog threads are designed with barbs (cogs) or cones for anchoring and mechanical lifting/tissue elevation, providing suspension."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "What is the material composition of Silhouette Soft® sutures, a type of suspension suture used in thread lifts?", options: ["Polydioxanone (PDO)", "Poly-L-Lactic Acid (PLLA)", "Polymethylmethacrylate (PMMA)", "Non-absorbable Polypropylene"], a: "Poly-L-Lactic Acid (PLLA)", exp: "Silhouette Soft® threads are made of PLLA, a biocompatible and resorbable polymer known for stimulating collagen production."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The injection of a dermal filler with a high Elastic Modulus (G') is generally preferred for which aesthetic goal?", options: ["Filling fine, superficial lines.", "Restoring hydration and tissue spread.", "Providing projection and lift to counteract gravity.", "Enhancing lip definition with a soft feel."], a: "Providing projection and lift to counteract gravity.", exp: "High G' materials resist deformation (push back) and provide greater lift, making them ideal for areas requiring projection like the cheeks, chin, and jawline. "},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which property of a Hyaluronic Acid (HA) filler describes the adhesion forces within the gel and measures how well it maintains shape against compression?", options: ["Viscosity", "Elasticity (G')", "Cohesion", "Water Uptake"], a: "Cohesion", exp: "Cohesion measures resistance to compression/stretching and dictates how the gel deposit maintains its shape once injected. Low cohesion $\\rightarrow$ easily molded/spread. "},
{topic: "Combined Treatments & Dermal Filler Basics", q: "A delayed complication of dermal fillers, typically seen $6$ months to years post-injection, is the formation of:", options: ["Bruising", "Swelling", "Granulomas", "Tyndall Effect"], a: "Granulomas", exp: "Granulomas are one of the most serious late complications, characterized by chronic inflammatory reaction to the foreign material."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which complication of dermal fillers results in a bluish discoloration due to superficial placement of the Hyaluronic Acid gel?", options: ["Tyndall Effect", "Vascular Occlusion", "Paresthesia", "Hyperpigmentation"], a: "Tyndall Effect", exp: "The Tyndall Effect is a scattering of light that occurs when HA filler is placed too superficially, making the area appear blue-tinged."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which is a common frequent adverse event of a thread lift, along with ecchymosis (bruising) and erythema (redness)?", options: ["Parotid gland duct rupture", "Nerve damage", "Facial asymmetry", "Chronic foreign body sensation"], a: "Facial asymmetry", exp: "Frequent adverse events include asymmetry, ecchymosis/hematoma, erythema/swelling, skin dimpling, and skin irregularities."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The filler Poly-L-Lactic Acid (PLLA) is classified as a 'semi-permanent absorbable filler' and its effects can last up to:", options: ["3 months", "6 months", "2 years", "5 years"], a: "2 years", exp: "PLLA (Sculptra) works by stimulating the body's own collagen production, with results lasting two years or more."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "A key instruction given to patients post-PLLA injection to maximize diffusion and prevent nodule formation is to:", options: ["Avoid touching the face for $7$ days.", "Massage the treated area for $5 \\text{ minutes}$, $5 \\text{ times a day}$, for $5 \\text{ days}$.", "Apply ice packs constantly for the first $24 \\text{ hours}$.", "Sleep on the back for $2 \\text{ weeks}$.",], a: "Massage the treated area for $5 \\text{ minutes}$, $5 \\text{ times a day}$, for $5 \\text{ days}$.", exp: "The '5-5-5 Rule' is essential post-PLLA injection to ensure uniform distribution of the product and minimize lump/nodule formation."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "When combining thread lifts and dermal fillers, what sequence of treatment is often preferred to allow for better assessment of volume needs?", options: ["Filler first, then threads immediately.", "Threads first, then filler $1-2 \\text{ weeks}$ later.", "Threads first, then filler immediately.", "BTX first, filler second, threads last."], a: "Threads first, then filler immediately.", exp: "The lifting and repositioning provided by threads should be done first, as the resultant volume restoration reduces the overall amount of filler needed. "},
{topic: "Combined Treatments & Dermal Filler Basics", q: "What is the primary aesthetic goal of using dermal fillers for soft tissue augmentation?", options: ["To permanently lift and suspend lax skin.", "To repair the basement membrane.", "To replenish lost volume and correct wrinkles/lines.", "To paralyze hyperactive muscles."], a: "To replenish lost volume and correct wrinkles/lines.", exp: "Dermal fillers are injected to address the most important physical factor of aging: volume loss, thereby softening lines and restoring contours."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which non-HA filler is comprised of Calcium Hydroxyapatite microspheres suspended in a gel carrier and works by inducing collagenesis?", options: ["Sculptra (PLLA)", "Bellafill (PMMA)", "Radiesse (CaHA)", "Zyderm (Collagen)"], a: "Radiesse (CaHA)", exp: "Radiesse is the brand name for Calcium Hydroxyapatite (CaHA), which provides immediate volume and long-term neocollagenesis. "},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Patients who are obese, have thick skin, or high cheekbones are considered poor candidates for thread lifts primarily due to:", options: ["Increased risk of infection.", "Inability to achieve sufficient lift or potential for thread protrusion.", "Higher risk of facial nerve damage.", "Severe post-operative edema."], a: "Inability to achieve sufficient lift or potential for thread protrusion.", exp: "Heavy or thick skin places too much tension on the thread/cog mechanism, preventing adequate lifting and increasing the risk of thread exposure."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which type of dermal filler has the longest expected duration of effect, classified as non-absorbable/permanent?", options: ["Collagen", "Hyaluronic Acid (HA)", "Poly-L-Lactic Acid (PLLA)", "Polymethylmethacrylate (PMMA)"], a: "Polymethylmethacrylate (PMMA)", exp: "PMMA (Artefill/Bellafill) is a non-absorbable synthetic polymer considered a permanent filler."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "What is the primary risk associated with injecting a low-cohesivity HA filler in high-compression areas (e.g., deeper nasolabial fold)?", options: ["Immediate Tyndall effect.", "Filler migration.", "Increased pain.", "Rapid degradation."], a: "Filler migration.", exp: "Low-cohesivity fillers resist compressive forces poorly, increasing the risk of product deformation and movement from the intended injection site."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "For correction of a fine, superficial wrinkle (dynamic or static), a dermal filler should ideally be placed into which skin layer?", options: ["Epidermis only", "Papillary Dermis", "Supraperiosteal Layer", "Hypodermis (Subcutaneous fat)"], a: "Papillary Dermis", exp: "Superficial (fine line) correction requires placement in the Papillary Dermis or the most superficial Reticular Dermis. "},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The delayed effect of Poly-L-Lactic Acid (PLLA) is due to its degradation into lactic acid and $\\text{CO}_2$ and water, which ultimately promotes:", options: ["Tissue necrosis and apoptosis.", "The formation of new Type-I collagen and fibroblast activity.", "Vasoconstriction and hemostasis.", "Immediate increase in blood vessel density."], a: "The formation of new Type-I collagen and fibroblast activity.", exp: "PLLA micro-particles stimulate a gradual inflammatory response that leads to neocollagenesis, providing the desired long-term volume replacement."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Why is Calcium Hydroxyapatite (CaHA) generally not recommended for lip augmentation?", options: ["It is too soft and diffuses too quickly.", "Due to the frequent occurrence of mucosal nodules/lumps.", "It has a short duration of effect in this area.", "It requires an allergic test patch."], a: "Due to the frequent occurrence of mucosal nodules/lumps.", exp: "CaHA (Radiesse) is not suitable for lip injection due to the frequent occurrence of palpable nodules in the mobile, thin mucosal tissue."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which anatomical factor contributes most to the progressive widening and shortening of the lower face with age?", options: ["Hypertrophy of the mentalis muscle.", "Skeletal changes involving bone remodeling in the maxilla and mandible.", "The lengthening of the philtrum.", "The constant activity of the depressor anguli oris (DAO)."], a: "Skeletal changes involving bone remodeling in the maxilla and mandible.", exp: "Bone resorption (remodeling) in the maxilla and mandible shortens the lower face and increases the mandibular angle, contributing to jowling and structural aging."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "A key feature of Hyaluronic Acid (HA) fillers is their ability to bind water at roughly how many times their own weight?", options: ["$10 \\times$", "$100 \\times$", "$1000 \\times$", "$10,000 \\times$"], a: "$1000 \\times$", exp: "HA is highly hydrophilic, binding water at roughly $1000$ times its own weight, which is essential for volumization and tissue hydration."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The term 'Viscosity' (measured as G\") of a dermal filler refers to the material's property that is analogous to the consistency of what substance?", options: ["A diamond (very hard).", "A rubber band (very elastic).", "Honey (viscous liquid).", "Water (non-viscous)."], a: "Honey (viscous liquid).", exp: "Viscosity (G\") measures the material's resistance to flow. A viscous liquid like honey loses mechanical energy through friction (viscous component)."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which property is increased in HA fillers with higher concentrations and greater degrees of cross-linking, which leads to more post-injection swelling?", options: ["Elastic Modulus (G')", "Viscosity (G\")", "Water Uptake (Swelling Factor)", "Cohesion"], a: "Water Uptake (Swelling Factor)", exp: "The hydrophilic nature of HA means that higher concentration and cross-linking $\\rightarrow$ greater water absorption $\\rightarrow$ increased swelling post-injection."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "In the aging face, the malar fat pad descends and bulges against the fixed nasolabial fold due to weakening of the fibrous septae and volume loss within which underlying deep compartment?", options: ["Infraorbital fat compartment.", "Middle cheek fat compartment.", "Deep medial cheek fat.", "Superficial temporal fat."], a: "Deep medial cheek fat.", exp: "Loss of volume in the deep medial cheek fat and weakening of supporting ligaments allow the superficial fat compartments to descend, creating the deepening nasolabial fold."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "What is the key functional difference between a sharp needle and a blunt-tip micro-cannula for widespread facial contouring (e.g., jawline, cheeks)?", options: ["Sharp needles can inject smaller volumes.", "Cannulas are safer as they are less likely to pierce and enter a vessel lumen.", "Sharp needles have less risk of bruising.", "Cannulas are better for superficial dermal placement."], a: "Cannulas are safer as they are less likely to pierce and enter a vessel lumen.", exp: "Blunt-tip cannulas navigate tissue planes by pushing structures aside, significantly lowering the risk of accidental vessel perforation, leading to less bruising and vascular compromise."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "When using PLLA, why are multiple injection sessions (typically three) generally required to achieve the desired cosmetic effect?", options: ["PLLA is absorbed too quickly in one session.", "The gradual effect stems from the host response (collagenesis) to the PLLA particles, not the initial volume.", "Patients cannot tolerate a large volume in one session.", "PLLA must be dissolved before the next layer is injected."], a: "The gradual effect stems from the host response (collagenesis) to the PLLA particles, not the initial volume.", exp: "The effect is delayed and subtle, relying on biological stimulation. Overcorrection in a single session is risky, necessitating staged treatments."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "What is the key advantage of a 'Mono' thread (smooth, short, placed in a mesh pattern) in a thread lift procedure?", options: ["Providing maximal mechanical lift.", "Stimulating collagenesis without direct lifting.", "Used only for lateral brow suspension.", "Non-absorbable suture material."], a: "Stimulating collagenesis without direct lifting.", exp: "Mono (or smooth) threads provide minimal lift but are highly effective at stimulating collagen production and improving skin quality and texture through tissue remodeling."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which type of non-HA filler is an acrylic polymer manufactured into microspheres and suspended in a gel solution, providing a lifting effect that remains underneath the skin?", options: ["Collagen", "Hyaluronic Acid", "Poly-L-Lactic Acid", "Polymethylmethacrylate (PMMA)"], a: "Polymethylmethacrylate (PMMA)", exp: "PMMA (Artefill/Bellafill) consists of permanent microspheres that provide continuous support. "},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which is considered a late complication of dermal fillers (occurring months to years post-injection)?", options: ["Bruising/Ecchymosis", "Swelling/Edema", "Infection/Biofilm formation", "Migration or Hypertrophic Scar"], a: "Migration or Hypertrophic Scar", exp: "Late complications include migration, granulomas, hypertrophic scars, and telangiectasias. Early/Immediate include bruising, swelling, and vascular occlusion."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "Which injection technique involves placing small deposits of filler material deeply onto the periosteum, commonly used in the midface for lifting?", options: ["Linear threading", "Cross-hatching", "Supraperiosteal depot (bolus)", "Fanning"], a: "Supraperiosteal depot (bolus)", exp: "Deep bolus injections, such as the De Maio technique, place concentrated filler directly on the bone to anchor tissue and restore skeletal support."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The concept of facial rejuvenation attempts to recreate the smooth S-shaped curvature from the lateral brow, through the cheek, and into the midface, known as the:", options: ["Golden Ratio (1.618)", "Square of Beauty", "Ogee Curve", "Triangle of Youth"], a: "Ogee Curve", exp: "The Ogee Curve (double S-curve) describes the youthful fullness in the cheeks that gently transitions to the midface contour. "},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The immediate concern following an accidental intra-arterial injection of HA filler is Vascular Occlusion, which must be treated by dissolving the filler with:", options: ["Prednisone (systemic steroid).", "Aspirin/Clopidogrel (anti-platelet drugs).", "Hyaluronidase (enzyme).", "Topical Nitroglycerin (vasodilator)."], a: "Hyaluronidase (enzyme).", exp: "Hyaluronidase is the only treatment that degrades the filler material itself, making it essential for reversing HA-related vascular occlusion."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "What is the primary function of Hyaluronic Acid (HA) in the extracellular matrix of human connective tissues?", options: ["Provides tensile strength to collagen fibers.", "Binds water for lubrication, hydration, and volume.", "Inhibits melanin synthesis.", "Regulates cellular apoptosis."], a: "Binds water for lubrication, hydration, and volume.", exp: "HA's unique property is its ability to attract and bind large amounts of water, crucial for skin hydration and structure."},
{topic: "Combined Treatments & Dermal Filler Basics", q: "The goal of Lip Augmentation is to enhance the appearance of the lips. For Caucasian patients, the ideal ratio of the upper lip to the lower lip is typically considered to be:", options: ["1:1", "1:2", "$1/3 \\text{ upper lip to } 2/3 \\text{ lower lip}$", "2/3 upper lip to $1/3 \\text{ lower lip}$"], a: "$1/3 \\text{ upper lip to } 2/3 \\text{ lower lip}$", exp: "The ideal Caucasian lip ratio often follows the $1:2$ rule, with the lower lip having slightly more volume than the upper lip. Black female lips often follow a $1:1$ ratio."},
];
// --- JAVASCRIPT LOGIC ---
const topics = [...new Set(ALL_QUESTIONS.map(q => q.topic))];
const fullQuizLength = ALL_QUESTIONS.length;
let currentQuestionIndex = 0;
let currentQuizData = [];
let score = 0;
let totalQuestionsAnswered = 0;
document.addEventListener('DOMContentLoaded', () => {
renderTopicList();
});
function renderTopicList() {
const topicList = document.getElementById('topic-list');
topicList.innerHTML = '';
// Add 'All Topics' option
const allTopicsButton = createTopicButton('All Topics', fullQuizLength);
topicList.appendChild(allTopicsButton);
topics.forEach(topic => {
const topicCount = ALL_QUESTIONS.filter(q => q.topic === topic).length;
const button = createTopicButton(topic, topicCount);
topicList.appendChild(button);
});
}
function createTopicButton(topic, count) {
const button = document.createElement('button');
button.className = 'w-full text-left p-4 rounded-lg bg-blue-100 hover:bg-blue-200 transition duration-150 font-medium text-blue-800 focus:outline-none focus:ring-4 focus:ring-blue-300 shadow-md';
button.innerHTML = `
<span class="text-lg">${topic}</span>
<span class="block text-sm text-gray-600">${count} Questions</span>
`;
button.onclick = () => startQuiz(topic);
return button;
}
function shuffleArray(array) {
for (let i = array.length - 1; i > 0; i--) {
const j = Math.floor(Math.random() * (i + 1));
[array[i], array[j]] = [array[j], array[i]];
}
}
function startQuiz(selectedTopic) {
if (selectedTopic === 'All Topics') {
currentQuizData = [...ALL_QUESTIONS];
} else {
currentQuizData = ALL_QUESTIONS.filter(q => q.topic === selectedTopic);
}
shuffleArray(currentQuizData);
currentQuestionIndex = 0;
score = 0;
totalQuestionsAnswered = 0;
document.getElementById('start-screen').classList.add('hidden');
document.getElementById('results-screen').classList.add('hidden');
document.getElementById('quiz-area').classList.remove('hidden');
document.getElementById('quiz-topic').textContent = selectedTopic;
loadQuestion();
}
function loadQuestion() {
if (currentQuestionIndex >= currentQuizData.length) {
showResults();
return;
}
const qData = currentQuizData[currentQuestionIndex];
const totalCount = currentQuizData.length;
document.getElementById('progress-indicator').textContent = `Question ${currentQuestionIndex + 1}/${totalCount}`;
document.getElementById('question-text').textContent = qData.q;
document.getElementById('feedback-area').classList.add('hidden');
document.getElementById('feedback-area').classList.remove('correct', 'incorrect');
const optionsContainer = document.getElementById('options-container');
optionsContainer.innerHTML = '';
// Shuffle options to prevent memorizing position
const shuffledOptions = [...qData.options];
shuffleArray(shuffledOptions);
shuffledOptions.forEach(option => {
const button = document.createElement('button');
button.className = 'option-button w-full text-left p-3 rounded-lg border-2 border-gray-200 bg-gray-50 hover:bg-gray-100 transition duration-150 focus:outline-none font-medium text-gray-800 shadow-sm';
button.textContent = option;
button.onclick = () => checkAnswer(button, option, qData.a, qData.exp);
optionsContainer.appendChild(button);
});
}
function checkAnswer(selectedButton, selectedOption, correctAnswer, explanation) {
// Disable all options
document.querySelectorAll('.option-button').forEach(btn => {
btn.disabled = true;
btn.classList.remove('hover:bg-gray-100');
});
totalQuestionsAnswered++;
const feedbackArea = document.getElementById('feedback-area');
const explanationText = document.getElementById('explanation-text');
if (selectedOption === correctAnswer) {
score++;
selectedButton.classList.add('correct', 'border-4');
explanationText.innerHTML = `<span class="text-green-700 font-bold">Correct!</span> <br> ${explanation}`;
feedbackArea.classList.add('correct');
feedbackArea.classList.remove('incorrect');
} else {
selectedButton.classList.add('incorrect', 'border-4');
feedbackArea.classList.add('incorrect');
feedbackArea.classList.remove('correct');
// Highlight the correct answer
document.querySelectorAll('.option-button').forEach(btn => {
if (btn.textContent === correctAnswer) {
btn.classList.add('correct', 'border-4');
}
});
explanationText.innerHTML = `<span class="text-red-700 font-bold">Incorrect. The correct answer was: ${correctAnswer}</span> <br> ${explanation}`;
}
feedbackArea.classList.remove('hidden');
}
function nextQuestion() {
currentQuestionIndex++;
loadQuestion();
}
function showResults() {
document.getElementById('quiz-area').classList.add('hidden');
document.getElementById('results-screen').classList.remove('hidden');
document.getElementById('score-display').textContent = `${score}/${totalQuestionsAnswered}`;
}
function resetQuiz() {
document.getElementById('results-screen').classList.add('hidden');
document.getElementById('start-screen').classList.remove('hidden');
renderTopicList(); // Re-render in case structure changed (though unlikely here)
}
</script>
</body>
</html>
✨ November Serene Deals! ✨ Save big on Neurotoxins, Morpheus 8, BBL, MOXI, Juvederm Fillers & VI Peels!💫 – Book Now